Angiotensin-converting enzyme is considered a major determinant of the control of blood pressure and cardiovascular-disease-related morbidity as it is responsible for releasing angiotensin-II, a potent vasoconstrictor, by cleaving angiotensin-I while simultaneously allowing renin inactivation of the vasomotor factor bradykinin in the angiotensin system, ultimately leading to enhanced vasoconstriction, which leads to hypertension [1]. Here, AGT is linked to cardiovascular disorder.